Inicio > Oncología > Mortalidad por metástasis cerebrales en La Habana > Página 10

Mortalidad por metástasis cerebrales en La Habana

Austria. September 2006; 2(2) Aoyama H, Shirato H, Tago M. Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006; 295:2483–2491.

Vecht CJ, Haaxma-Reiche H, Noordijk EM. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 2008; 33(6):583–90.

Gaspar L. Validation of the RTOG recursive partition in RPA classification for brain metastases. Proc Am Soc Ther Radiat Oncol (ASTRO); 1998. Int J Radiat Oncol Biol Phys. 2003; 42(1):260.

Weltman E. Int J Radiat Oncol Biol Phys 2000, SperdutoPW. What is your patient’s GPA and why does it matter? Managing brain metastases and the cost of hope. Int J Radiat Oncol Bio lPhys2010; 77:643-644.

Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000; 47(23):1001–1006.

Plotkin SR, Wen PY. Brain metastases. In: Samuels MA, Feske SK, editors. Office practice of neurology, Edition 2. Philadelphia: Churchill Livingstone; 2003; 1101–1106.

Martin J. van den Bent The diagnosis and management of brain metastases Current Opinion in Neurology 2001, 14:717±723.

Kocher M, Soffietti R, Abacioglu U, et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study J Clin Oncol 29 134–41

Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322(8):494–500.

Maraveyas A, Sgouros J, Upadhyay S, et al. Gemcitabine twice weekly as a radiosensitive for the treatment of brain metastases in patients with carcinoma: a phase I study. Br J Cancer 2009; 92:815–819.

Hart MG, Grant R, Walker M, Dickinson H. Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases. Cochrane Database Syst Rev 2005 ;( 110-113).

Stark AM, Tscheslog H, Buhl R, et al. Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev 2005; 115–119.

Chao JH, et al. Roetgen-ray therapy of cerebral metastases. Cancer. 2004; 7:682.

Sperduto PW, Scott C, Andrews D. Preliminary report of RTOG 9508: a phase III trial comparing whole brain irradiation alone versus whole brain irradiation plus stereotactic radiosurgery for patients with two or three unresected brain metastases. Int J Radiat Oncol Biol Phys 2000; 48 (Suppl.):113.

Patchell RA, Tibbs PA, Walsh JW. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322:494–500.

Vecht CJ, Haaxma-Reiche H, Noordijk EM. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993; 33:583–590. una 1 supervivencia del año de sólo 12 ( Lagerwaard FJ, Levendag PC, Nowak PJCM, et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999; 43:795±803.

Patchell RA, Cirrincione C, Thaler HT. Single brain metastases: surgery plus radiation or radiation alone. Neurology 2006; 36:447-53.

Black PM, Johnson MD. Surgical resection for patients with solid brain metastases: current status. J Neurooncol 2004; 69:119–124.

Tsao MN, Management of brain metastases: role of radiotherapy alone or in combination with other treatment modalities. Supportive Care Guidelines group, Neuro-oncology Disease Site Group. Cancer Care Ontario, 2004; Practice guideline report, n.os 13-4.

Kihlstrom L. Gamma Knife for cerebral metastases: implications for survival based on 16 years experience. Stereotact Funct Neurosurg. 2009; 61(Suppl 1):45-50.

Maraveyas A, Sgouros J, Upadhyay S. Gemcitabine twice weekly as a radiosensitive for the treatment of brain metastases in patients with carcinoma: a phase I study. Br J Cancer 2009; 92:815–819.

Patil CG, Pricola K, Garg SK, Bryant A, Black KL. Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases (Review) the Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Sep 12, 2012

Chougule PB, Burton-WilliamsM, Saris S. Randomized treatment of brain metastases with gamma knife radiosurgery, whole brain radiotherapy or both. Int J Radiat Oncol Biol Phys 2000; 48(Suppl.):114.

Sneed PK, Lamborn KR, Forstner JM. Radiosurgery for brain metastases; is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 1999; 43:549±558.

7th Congress of the European Association for Neurooncology Vienna, Austria. September 2006; 2(2):14-17.

Aoyama H, Shirato H, Tago M. Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006; 295:2483–2491.

Tsao MN, Lloyd NS, Wong RK. Radiotherapeutic management of brain metastases: A systematic review and meta-analysis. Cancer Treat Rev 2005; 31:256–273.

Suh JH, Stea B, Nabid A. Standard whole brain radiation therapy plus supplemental oxygen with or without efaproxiral (EFAPROXYNTM) in patients with brain metastases: updated survival results of the randomized REACH (RT-009) study. Ann Oncol 2004; 15:iii207.

Abrey LE, Olson JD, Raizer JJ. A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 2001; 53:259–65.

Suh JH, Stea B, Nabid A. Phase III study of efaproxiral as an adjunct to whole brain radiation therapy for brain metastases. J Clin Oncol 2006; 24(1):106–14.

Bendell JC, Domchek SM, Burstein HJ. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 2008; 97: 2972–77.

Hofmann M, Kiecker F, Wurm R. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J Neurooncol 2006; 76:59-64.

Agarwala SS, Kirkwood JM, Gore M. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol 2006; 22(11):2101–7.

Antonadou D, Paraskevaidis M, Sarris G. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002; 20(17):3644–50.

Namba Y, Kijima T, Yokota S. Gefitinib in patients with brain metastases from nonsmall-cell lung cancer: review of 15 clinical cases. Clin Lung Cancer 2009; 6(2):123–8.

Crivellari D, Pagani O, Veronesi A. High incidence of central nervous system